Live
Clinical OMICsAI-Powered Blood Test Detects Early Retinal Damage in DiabetesClinical OMICsMature Intestinal Cells Revert to Stem-Like State to Sustain Colorectal CancerFierceBiotechFoundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer comboFierceBiotechNew heights for NewLimit as anti-aging biotech nabs $435M to rejuvenate old cellsEndpoints NewsLilly gives hospitals deadline to comply with 340B claims data policyEndpoints NewsFDA details flexibilities for new cell and gene therapies to leverage past dataEndpoints NewsAnti-aging biotech NewLimit raises $435M at $3B+ valuationBioPharma DiveEli Lilly issues data sharing ultimatum to 340B hospitalsFierceBiotechASCO: Roche, head held high, details oral SERD's first-line flop in breast cancerBioPharma DiveFulcrum exploring a potential sale after FDA sidelined its sickle cell drugEndpoints NewsWhat’s next for VEGF? #ASCO26 offered clues, but answers will have to waitBioWorldLongbio to raise HK$1.4B in Hong Kong IPO for immunology work
FierceBiotech Apr 17, 2026

UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine

UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine

Original
Body unavailable. Use the original source.